Form 4 for IDXX Idexx Laboratories
Accepted 2026-02-11 00:00:00 ET · period of report 2026-02-09 · accession 0000874716-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-11 | 2026-02-10 | IDXX | FENNELL GEORGE | EVP | S - Sale+OE | $646.72 | -11.3K | 14.7K | -44% | -$7.34M |
| DM | 2026-02-11 | 2026-02-09+ | IDXX | FENNELL GEORGE | EVP | M - OptEx | $67.85 | +12.8K | 9,823 | New | +$869.9K |
| DM | 2026-02-11 | 2026-02-09+ | IDXX | FENNELL GEORGE | EVP | M - OptEx | $0.00 | -12.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-10 | S | D | 1,130 | $643.00 | 20,038 | D | — | — | (F1) Represents the weighted average price of the shares sold ranging from a low of $642.595 to a high of $643.47 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 2 | Common | Common Stock | 2026-02-10 | S | D | 397 | $644.02 | 19,641 | D | — | — | (F2) Represents the weighted average price of the shares sold ranging from a low of $643.65 to a high of $644.47 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 3 | Common | Common Stock | 2026-02-10 | S | D | 2,161 | $645.25 | 17,480 | D | — | — | (F3) Represents the weighted average price of the shares sold ranging from a low of $644.75 to a high of $645.60 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 4 | Common | Common Stock | 2026-02-10 | S | D | 1,060 | $647.21 | 13,638 | D | — | — | (F5) Represents the weighted average price of the shares sold ranging from a low of $646.825 to a high of $647.69 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 5 | Common | Common Stock | 2026-02-10 | S | D | 966 | $648.78 | 12,672 | D | — | — | (F6) Represents the weighted average price of the shares sold ranging from a low of $648.02 to a high of $649.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 6 | Common | Common Stock | 2026-02-10 | S | D | 2,809 | $649.26 | 9,863 | D | — | — | (F7) Represents the weighted average price of the shares sold ranging from a low of $649.05 to a high of $649.72 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 7 | Common | Common Stock | 2026-02-10 | S | D | 40 | $650.32 | 9,823 | D | — | — | |
| 8 | Common | Common Stock | 2026-02-10 | M | A | 11,345 | $67.85 | 21,168 | D | — | — | |
| 9 | Common | Common Stock | 2026-02-09 | M | A | 1,476 | $67.85 | 9,823 | D | — | — | |
| 10 | Common | Common Stock | 2026-02-10 | S | D | 2,782 | $646.23 | 14,698 | D | — | — | (F4) Represents the weighted average price of the shares sold ranging from a low of $645.80 to a high of $646.71 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 11 | Derivative | Incentive Stock Option (right-to-buy) | 2026-02-09 | M | D | 1,476 | $0.00 | 0 | D | $67.85 · — to 2026-02-13 | 1,476 Common Stock | (F8) Grant of option to buy 1,476 shares of Issuer common stock that vested on February 14, 2021. |
| 12 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2026-02-10 | M | D | 11,345 | $0.00 | 0 | D | $67.85 · — to 2026-02-13 | 11,345 Common Stock | (F9) Grant of option to buy 11,345 shares of Issuer common stock that vested in five annual installments beginning on February 14, 2017. |